Biopharma execs rethink Trump impact after FDA cutsnews2025-04-02T19:47:10+00:00April 2nd, 2025|Endpoints News|
Atsena raises $150M to target rare form of blindness with gene therapynews2025-04-02T11:30:59+00:00April 2nd, 2025|Endpoints News|
New CDMO emerges, acquires cell and gene manufacturer Landmark Bionews2025-04-02T09:00:38+00:00April 2nd, 2025|Endpoints News|
DC court sides with HHS in Vertex’s fertility program fightnews2025-03-31T19:57:10+00:00March 31st, 2025|Endpoints News|
Heart gene therapy company Tenaya to lay off 30% to 40% of staffnews2025-03-31T19:45:52+00:00March 31st, 2025|Endpoints News|
Stem cell company bit.bio lays off quarter of staffnews2025-03-18T19:38:01+00:00March 18th, 2025|Endpoints News|
Sixteen-year-old dies after receiving Sarepta’s Duchenne therapy Elevidysnews2025-03-18T13:21:46+00:00March 18th, 2025|Endpoints News|
Orca Bio’s T cell therapy may help blood cancer patients avoid transplant issuesnews2025-03-17T15:16:35+00:00March 17th, 2025|Endpoints News|
AstraZeneca to buy cell therapy startup EsoBiotec for $425M upfrontnews2025-03-17T10:33:40+00:00March 17th, 2025|Endpoints News|
